# Prestoma-Trial for Parastomal Hernia Prevention

> **NCT03527784** · NA · TERMINATED · sponsor: **University of Oulu** · enrollment: 14 (actual)

## Conditions studied

- Rectal Adenocarcinoma

## Interventions

- **DEVICE:** Parietene Macro
- **DEVICE:** Parietex Parastomal
- **DEVICE:** Dynamesh IPST

## Key facts

- **NCT ID:** NCT03527784
- **Lead sponsor:** University of Oulu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-03
- **Primary completion:** 2018-10-29
- **Final completion:** 2018-10-29
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Parastomal Parietex withdrawn from market by the manufacturer.
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03527784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03527784, "Prestoma-Trial for Parastomal Hernia Prevention". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03527784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*